2020
DOI: 10.1016/j.toxlet.2020.07.013
|View full text |Cite
|
Sign up to set email alerts
|

In utero exposure to genistein decreased intranasal house dust mite-induced respiratory allergy in middle-aged male B6C3F1 offspring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 56 publications
0
4
0
Order By: Relevance
“…To understand whether intrauterine exposure to genistein modulates postnatal respiratory allergies in middle age, a study was conducted. The use of genistein in the intrauterine period (by gavage; 20 mg/kg body weight) had a protective effect on respiratory allergies in male offspring [147].…”
Section: Genistein and Pregnancymentioning
confidence: 97%
“…To understand whether intrauterine exposure to genistein modulates postnatal respiratory allergies in middle age, a study was conducted. The use of genistein in the intrauterine period (by gavage; 20 mg/kg body weight) had a protective effect on respiratory allergies in male offspring [147].…”
Section: Genistein and Pregnancymentioning
confidence: 97%
“…In 2006, a systematic review showed that the use of SF in infants had no apparent effect in the prevention of allergy or food intolerance 1 . However, more recent studies have demonstrated the role of soy isoflavones as immunomodulators in allergic disease development 2–6 . For example, in utero exposure to the soy isoflavone genistein may decrease house dust mite‐induced respiratory allergy as indicated by decreases in airway hyperresponsiveness, house dust mite‐specific IgG1 levels, and pulmonary eosinophil peroxidase activity in a murine model 2 .…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4][5][6] For example, in utero exposure to the soy isoflavone genistein may decrease house dust mite-induced respiratory allergy as indicated by decreases in airway hyperresponsiveness, house dust mite-specific IgG1 levels, and pulmonary eosinophil peroxidase activity in a murine model. 2 Cho et al 3 showed that soy isoflavone treatment in patients with asthma can reduce plasma plasminogen activator inhibitor-1 levels and the frequency of asthma exacerbations that require oral corticosteroids. Furthermore, Park et al 4 demonstrated that 7,3′,4′-trihydroxyisoflavone, which features an additional -OH group bonded to the soy isoflavone daidzein at the ortho position on the B ring, decreases the levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in human skin keratinocytes, and also alleviates symptoms of atopic dermatitis in a murine model.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation